BioPharma Clinical Trials

Two leaders in science combine complementary best-in-class technologies for biologics manufacturing customers

Solution enables manufacturers to optimize manufacturing capacity, quality, efficiency and scalability 3M Separation and Purification Sciences announ...

 November 01, 2021 | News

Xcell Therapeutics opens an export route for cell therapy culture technology.

In a hair follicle, there are "dermal follicle papilla cells" that appear 3,000 grapes clustered together. The name was given because its outline resemble...

 October 29, 2021 | News

Novavax Files for Authorization of its COVID-19 Vaccine in the United Kingdom

All modules required for regulatory review, including CMC data, are now complete Submission based on Phase 3 data from ~45K patients demonstrating high ...

 October 28, 2021 | News

SCN9A Antisense Pain Killer OLP-1002 Moves into Phase 2a Stage

In the Phase 2a trial of a two stage adaptive design in OA patients with pain, OLP-1002 shall be evaluated for analgesic efficacy, safety and therapeutic d...

 October 26, 2021 | News

Hummingbird Bioscience collaborates with Merck for a clinical trial on HMBD-002, our anti-VISTA antibody, in combination with KEYTRUDA®

  Under this collaboration, Hummingbird will evaluate the safety, tolerability, and anti-tumor activity of its novel anti-VISTA antibody, HMBD-002, i...

 October 26, 2021 | News

AstraZeneca launches Clinical Data and Insights division in India

The Clinical Data & Insights team in Bengaluru, India, is a critical advancement to support a growing global portfolio, and build on internal data expe...

 October 20, 2021 | News

FDA Pre-Submission for Saliva-Based Glucose Test to Replace Invasive Finger-Prick

The purpose of this Pre-Submission is to confirm with the FDA the clinical trial design, including trial objectives. This interaction will allow the FDA to...

 October 20, 2021 | News

MYND to Participate in a Monash University (Australia) Proposal for $3 Million Clinical Trial

MYND Diagnostics Inc., a wholly-owned subsidiary of MYND Life Sciences (CSE: MYND) (OTC: MYNDF) is pleased to announce that the Company's pr...

 October 18, 2021 | News

Biocytogen announces collaboration with Envigo

Biocytogen announces a collaboration with Envigo, a global organization that offers the widest range of research models and related services. The two compa...

 September 29, 2021 | News

ACROMEC's associated Life Science Incubator launches Co-working Labspace

ACROMEC Limited a specialist engineering services provider, announced that subsidiary ACROMEC Engineers Pte Ltd (ACROMEC Engineers) through joint-venture a...

 September 24, 2021 | News

Singapore Approved New Therapy to Treat Advanced Small Cell Lung Cancer

  ZEPZELCA® (lurbinectedin) is the first new therapy approved in Singapore to treat 2L metastatic small cell lung cancer (SCLC) in 20...

 September 23, 2021 | News

Bionomics Prepares BNC210 for Start of Phase 2 Acute Treatment of Social Anxiety Disorder Trial

  Rapid oral absorption of BNC210 novel tablet formulation potentially well-suited for acute treatment of anxiety in patients with Social Anxiety D...

 September 21, 2021 | News

Jemincare declared Ph I trial of its anti-SARS-CoV-2 neutralizing antibody

The clinical trial of JMB2002 was stated in January 2021. A single-center, randomized, double-blind, placebo-controlled, single-dose escalation phas...

 September 14, 2021 | News

Novavax Launches Ph 1 & 2 ,Clinical Trial of Combined COVID-19 and Seasonal Influenza Vaccine

First participants enrolled in Phase 1 clinical trial of NanoFlu combination vaccineTM/NVX–CoV2373 with Matrix-M adjuvantTM Novavax, Inc. (Nasdaq:&n...

 September 11, 2021 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close